Mesenchymal stem cell therapy on top of triple therapy with remdesivir, dexamethasone, and tocilizumab improves PaO2/FiO2 in severe COVID-19 pneumonia
瑞德西韦、地塞米松和托珠单抗三联疗法联合间充质干细胞疗法可改善重症 COVID-19 肺炎患者的 PaO2/FiO2
期刊:Frontiers in Medicine
影响因子:
doi:10.3389/fmed.2022.1001979
Chih-Hao Chen, Kuan-Cheng Chang, Yen-Nien Lin, Mao-Wang Ho, Meng-Yu Cheng, Wen-Hsin Shih, Chia-Huei Chou, Po-Chang Lin, Chih-Yu Chi, Min-Chi Lu, Ni Tien, Mei-Yao Wu, Shih-Sheng Chang, Wu-Huei Hsu, Woei-Cheang Shyu, Der-Yang Cho, Long-Bin Jeng4